Sveriges mest populära poddar
Plenary Session
Hälsa och motionMedicin

1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints

34 min•20 september 2018
Special episode! We discuss the recent correspondence in NEJM on response rate in phase I clinical trials, the JACOB trial published in The Lancet Oncology on pertuzumab for HER2-positive gastric cancer, and we give an evaluation of MI, stroke, and metastasis as hard endpoints.

Fler avsnitt av Plenary Session

Visa alla avsnitt av Plenary Session
Longevity Lecture series Introduction and Lecture 1
•29 min
CABINET - trial - Cabozantinib for NET
•19 min
CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!
•39 min
Why the NIH is a broken funding system
•32 min
Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints
•23 min
Trump is breaking media brains / NIH cuts indirect payments and scientists freak out
•27 min
RFK Jr takes office/ CDC layoffs/ Varmus criticizes Jay's proposal for Academic Freedom
•28 min
Trump's Big Health Care Changes: NIH study sections, MMWR gag order, WHO withdrawal & more!
•29 min
The ENTIRE healthcare system is broken, not just health insurance companies
•19 min
Alcohol - Is it healthy? Everything you need to know about Beer, Wine and Spirits
•41 min

Plenary Session med Vinay Prasad, MD MPH finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.